Page last updated: 2024-08-23

mefloquine and Central Nervous System Disease

mefloquine has been researched along with Central Nervous System Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (66.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, LL; Eick-Cost, AA; Hu, Z; Rohrbeck, P	1
Cambon, N; Chalermrut, K; Krudsood, S; Looareesuwan, S; Mueller, EA; Pittrow, D; Silachamroon, U	1
Haller, A; Speich, R	1
Ellis-Pegler, RB; Ingram, RJ	1
Suzuki, M	1

Reviews

2 review(s) available for mefloquine and Central Nervous System Disease

Article	Year
Mefloquine and malaria prophylaxis. Drug and therapeutics bulletin, 1998, Volume: 36, Issue:3 Topics: Antimalarials; Central Nervous System Diseases; Drug Administration Schedule; Humans; Malaria, Falciparum; Mefloquine	1998
[Neurological toxicity of antifungal and antiprotozoal drugs]. Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2 Topics: Amphotericin B; Antifungal Agents; Antimalarials; Antiprotozoal Agents; Antitrichomonal Agents; Central Nervous System Diseases; Chloroquine; Humans; Mefloquine; Metronidazole; Quinine	1999

Trials

1 trial(s) available for mefloquine and Central Nervous System Disease

Article	Year
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand. The American journal of tropical medicine and hygiene, 2002, Volume: 67, Issue:5 Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Central Nervous System Diseases; Child; Double-Blind Method; Drug Administration Schedule; Drug Packaging; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Falciparum; Male; Mefloquine; Nausea; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome	2002

Article

Year

Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.

The American journal of tropical medicine and hygiene, 2002, Volume: 67, Issue:5

Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Central Nervous System Diseases; Child; Double-Blind Method; Drug Administration Schedule; Drug Packaging; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Falciparum; Male; Mefloquine; Nausea; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome

2002

Other Studies

3 other study(ies) available for mefloquine and Central Nervous System Disease

Article	Year
Neuropsychiatric Outcomes After Mefloquine Exposure Among U.S. Military Service Members. The American journal of tropical medicine and hygiene, 2017, Jan-11, Volume: 96, Issue:1 Topics: Adolescent; Adult; Antimalarials; Central Nervous System Diseases; Cohort Studies; Doxycycline; Female; Humans; Male; Mefloquine; Military Personnel; Retrospective Studies; United States; Young Adult	2017
Central anticholinergic syndrome with the antimalarial drug mefloquine. The New England journal of medicine, 1994, Jul-07, Volume: 331, Issue:1 Topics: Central Nervous System Diseases; Delirium; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Syndrome	1994
Malaria, mefloquine and the mind. The New Zealand medical journal, 1997, Apr-25, Volume: 110, Issue:1042 Topics: Antimalarials; Central Nervous System Diseases; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Travel	1997